工程细胞膜涂层的纳米粒子:质瘤向治疗和免疫调节的新策略
Yilei Ma1,2, Jia Yi1, Jing Ruan1
1Institute of Life Sciences & Biomedical Collaborative Innovation Center of Zhejiang Province, Wenzhou University, Wenzhou, 325035, China.
Advanced healthcare materials
|April 23, 2024
概括
工程细胞膜提供了一种有希望的方法来克服质瘤治疗的挑战,通过改善通过血脑屏障传递药物并调节瘤微环境以提高治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- 质瘤是最常见的原发性脑瘤,由于其复杂性,具有重大治疗挑战.
- 血脑屏障 (BBB) 和瘤微环境 (TME) 限制了手术和化疗等传统治疗的疗效.
- 工程细胞膜技术为解决这些局限性提供了一种新的策略.
研究的目的:
- 审查用于质瘤治疗的工程细胞膜技术的进展.
- 探索工程细胞膜在向药物输送和免疫微环境调制中的应用.
- 突出工程细胞膜涂层纳米粒子 (ECM-NP) 在克服传统治疗约束方面的潜力.
主要方法:
- 对细胞膜的物理,化学和遗传修饰进行治疗应用的审查.
- 分析ECM-NP与质瘤TME的相互作用及其在调节瘤细胞行为中的作用.
- 研究ECM-NP对增强免疫调节的免疫反应的影响.
主要成果:
- 工程细胞膜,特别是ECM-NP,显示了改善整个BBB的药物输送的潜力.
- ECM-NP可以调节质瘤细胞行为和TME,提高治疗疗效.
- 在质瘤的背景下,ECM-NPs在免疫调节策略方面表现有前途.
结论:
- 工程细胞膜技术为克服目前质瘤治疗的局限性提供了一个有希望的途径.
- ECM-NP代表了一种新的方法,具有针对性药物输送和质瘤免疫调节的潜力.
- 未来的研究应该专注于提高膜稳定性和可扩展性的临床翻译.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520